These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38915227)

  • 1. Long-term outcomes of lobectomy vs . sublobectomy for stage I lung invasive mucinous adenocarcinoma.
    Wang L; Zhang G; Zheng C; Zhang L; Jia J; Xue L; Gao S; Gao Y; Tan F; Xue Q
    Chin Med J (Engl); 2024 Aug; 137(15):1879-1881. PubMed ID: 38915227
    [No Abstract]   [Full Text] [Related]  

  • 2. Limited resection is comparable to lobectomy for tumor size ≤ 2 cm pulmonary invasive mucinous adenocarcinoma.
    Lin W; Su H; Xie H; Xu L; Wang T; Wang L; Hu X; Zhao D; Zhu Y; Wang H; Jiang G; Xie D; Chen C;
    World J Surg Oncol; 2024 Apr; 22(1):109. PubMed ID: 38664816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for Stage I nonsmall cell lung cancer: A meta-analysis.
    Liu Q; Wang H; Zhou D; Deng X; Min J; Dai J
    J Cancer Res Ther; 2016; 12(2):926-31. PubMed ID: 27461676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer.
    Mu JW; Gao SG; Xue Q; Zhao J; Li N; Yang K; Su K; Yuan ZY; He J
    Chin Med J (Engl); 2015 Oct; 128(20):2731-5. PubMed ID: 26481738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobectomy Versus Sublobectomy in Metachronous Second Primary Lung Cancer: A Propensity Score Study.
    Yang X; Zhan C; Li M; Huang Y; Zhao M; Yang X; Lin Z; Shi Y; Jiang W; Wang Q
    Ann Thorac Surg; 2018 Sep; 106(3):880-887. PubMed ID: 29852145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of pulmonary mucinous cystic tumor of borderline malignancy.
    Mann GN; Wilczynski SP; Sager K; Grannis FW
    Ann Thorac Surg; 2001 Feb; 71(2):696-7. PubMed ID: 11235730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (≤2 cm) invasive lung adenocarcinoma: A population-based study.
    Li F; Zhao Y; Yuan L; Wang S; Mao Y
    J Surg Oncol; 2020 Jun; 121(7):1132-1139. PubMed ID: 32108349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachronous cancers or late recurrences after resection of stage I lung cancer.
    Lenner R; Teirstein AS; Krellenstein DJ
    Ann Thorac Surg; 1999 Feb; 67(2):548-9. PubMed ID: 10197693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress of Sublobectomy for the Treatment of Stage I Non-small Cell Lung Cancer in the Elderly].
    Dong S; Zhang L
    Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):710-714. PubMed ID: 29061219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly.
    Qiu C; Wang G; Xu J; Cui L; Dong W; Ni Y; Qu X; Du J
    Int J Surg; 2017 Jan; 37():1-7. PubMed ID: 27890654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
    Kagimoto A; Tsutani Y; Kushitani K; Kai Y; Kambara T; Miyata Y; Takeshima Y; Okada M
    Ann Thorac Surg; 2021 Sep; 112(3):935-943. PubMed ID: 33144104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
    Genova SN; Belovezhdov VT; Bichev SN; Danev VH
    Folia Med (Plovdiv); 2017 Jun; 59(2):174-182. PubMed ID: 28704186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer ≤2 cm: A propensity score analysis.
    Yin J; Zhao M; Lu T; Huang Y; Sui Q; Xi J; Lin Z; Xu S; Wang Q; Zhan C
    J Surg Oncol; 2019 Dec; 120(8):1486-1496. PubMed ID: 31602661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublobectomy for stage IA1-2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25.
    Qi YF; Qiu ZB; Zhang C; Fu R; Yang XW; Chu XP; Chen ZH; Yang XN; Wu YL; Zhong WZ
    Thorac Cancer; 2022 Nov; 13(22):3174-3182. PubMed ID: 36208139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.
    Berry MF; Worni M; Wang X; Harpole DH; D'Amico TA; Onaitis MW
    Ann Thorac Surg; 2014 Jan; 97(1):230-5. PubMed ID: 24206972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.
    Matsui T; Sakakura N; Koyama S; Nakanishi K; Sasaki E; Kato S; Hosoda W; Murakami Y; Kuroda H; Yatabe Y
    Ann Thorac Surg; 2021 Oct; 112(4):1118-1126. PubMed ID: 33242433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.
    Strand TE; Rostad H; Strøm EH; Hasleton P
    Diagn Pathol; 2015 Jul; 10():94. PubMed ID: 26159539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical analysis of the impact of sublobectomy on pulmonary function.
    Yang H; Yun Y; Mao Y
    Medicine (Baltimore); 2017 Dec; 96(49):e8662. PubMed ID: 29245226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database.
    Chen C; Wu Z; Wu Z; Wu C; Wang Q; Zhan T; Dong L; Fang S; Wu M
    BMC Cancer; 2021 Jun; 21(1):666. PubMed ID: 34088283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous (colloid) adenocarcinoma.
    Okimasa S; Kurimoto N
    Jpn J Thorac Cardiovasc Surg; 2005 Jun; 53(6):305-8. PubMed ID: 15997752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.